July 11, 2019

Sage Therapeutics

Sage Therapeutics to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019sa

July 10, 2019

TARIS Bio

TARIS Initiates Clinical Trial of TAR-200 in Combination with Opdivo® (nivolumab) for Patients with Muscle-Invasive Bladder Cancer

July 10, 2019

GBT

GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease

July 09, 2019

REVOLUTION Medicines

REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers

July 09, 2019

Maze Therapeutics

Maze Therapeutics Appoints Drug Development Expert Richard Scheller, Ph.D., to its Board of Directorsm

Load More

Sign up for weekly portfolio news.